Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219680 · ClinicalTrials.gov registry record · NA
Intervention for Communication Quality of Life in Primary Progressive Aphasia
A NA study of Logopenic Progressive Aphasia and Primary Progressive Aphasia(PPA), sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT07219680: Recruiting NA study of Logopenic Progressive Aphasia and Primary Progressive Aphasia(PPA), sponsored by University of Texas at Austin.
NCT07219680 is a NA study of Logopenic Progressive Aphasia and Primary Progressive Aphasia(PPA) that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 25 participants, below the 84-participant average among 5 other Logopenic Progressive Aphasia trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07219680, a NA study of Logopenic Progressive Aphasia and Primary Progressive Aphasia(PPA), is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to determine whether individually tailored speech-language telerehabilitation helps improve communication in people with primary progressive aphasia (PPA), a form of dementia that affects speech and language. The study will be offered to individuals who speak English and/or Spanish. The study will also document how acceptable and beneficial the program is to both patients and their care partners. The main questions the study aims to answer are: 1. Is the telerehabilitation program feasible and acceptable for people with PPA and their care partners? 2. Do participants with PPA and care partners find treatment beneficial? 3. Which outcome measures are most useful for evaluating changes in communication and quality of life? 4. What patterns of treatment response are seen in participants after completing the program? The program includes both speech-language therapy and training for care partners. Participants with PPA will: 1. Complete virtual communication tasks and questionnaires before and after the program 2. Take part in online speech-language therapy sessions 3. Include their care partners in some parts of the program for training and support
Primary Outcome
Percent correctly named trained/untrained pictures
Conditions Studied
Interventions
- BEHAVIORAL Multicomponent Lexical Retrieval Training
- BEHAVIORAL Multicomponent Video Implemented Script Training in Aphasia
Study Locations (1)
Texas
- University of Texas - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-01-03 |
| Est. Completion | 2027-08 |
| Phase | NA |
What NCT07219680 shows while recruiting
NCT07219680 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 84-participant average among 5 other Logopenic Progressive Aphasia trials with a reported enrollment target (70% lower).
The record links to 10 conditions, with Logopenic Progressive Aphasia appearing as the primary indexed condition, and to 2 interventions - of which Multicomponent Lexical Retrieval Training is the first listed.
NCT07219680 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07219680 about?
NCT07219680 is a clinical study titled "Intervention for Communication Quality of Life in Primary Progressive Aphasia". The goal of this clinical trial is to determine whether individually tailored speech-language telerehabilitation helps improve communication in people with primary progressive aphasia (PPA), a form of dementia that affects speech and language. The study will be offered to individuals who speak Engli...
What is the current status of trial NCT07219680?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-01-03. Estimated completion is 2027-08.
What conditions does trial NCT07219680 study?
This clinical trial studies the following conditions: Logopenic Progressive Aphasia, Primary Progressive Aphasia(PPA), Semantic Dementia, Logopenic Progressive Aphasia (LPA), Progressive Aphasia.
What interventions are being tested in trial NCT07219680?
The interventions under investigation include: Multicomponent Lexical Retrieval Training (BEHAVIORAL), Multicomponent Video Implemented Script Training in Aphasia (BEHAVIORAL).
Who is sponsoring clinical trial NCT07219680?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07219680 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Logopenic Progressive Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease
RECRUITING · NA
-
Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA
RECRUITING · NA
-
Treatment for Speech and Language in Primary Progressive Aphasia
ACTIVE NOT RECRUITING · NA
-
Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
RECRUITING · Phase 2
-
Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI